Financial results - INVICTUS PHARMACEUTICAL S.R.L.

Financial Summary - Invictus Pharmaceutical S.r.l.
Unique identification code: 39517135
Registration number: J40/8797/2018
Nace: 4646
Sales - Ron
10.770
Net Profit - Ron
-7.483
Employees
1
Open Account
Company Invictus Pharmaceutical S.r.l. with Fiscal Code 39517135 recorded a turnover of 2024 of 10.770, with a net profit of -7.483 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Invictus Pharmaceutical S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 0 14.054 30.091 8.341 1.977 3.471 10.770
Total Income - EUR - - - 0 14.054 30.092 8.341 1.977 3.471 10.770
Total Expenses - EUR - - - 2.175 19.444 15.060 11.122 8.501 13.754 18.252
Gross Profit/Loss - EUR - - - -2.175 -5.390 15.032 -2.780 -6.524 -10.283 -7.483
Net Profit/Loss - EUR - - - -2.175 -5.599 14.227 -3.030 -6.584 -10.317 -7.483
Employees - - - 1 1 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 212.0%, from 3.471 euro in the year 2023, to 10.770 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Invictus Pharmaceutical S.r.l.

Rating financiar

Financial Rating -
INVICTUS PHARMACEUTICAL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Invictus Pharmaceutical S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Invictus Pharmaceutical S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Invictus Pharmaceutical S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Invictus Pharmaceutical S.r.l. - CUI 39517135

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 26 126 0 15.010 11.143 9.634 3.706
Current Assets - - - 1.121 2.848 8.005 4.658 5.672 3.567 6.645
Inventories - - - 0 0 0 0 2.393 827 27
Receivables - - - 1.119 2.574 3.816 2.683 2.007 2.653 4.082
Cash - - - 2 274 4.189 1.975 1.272 87 2.536
Shareholders Funds - - - -2.089 -7.648 6.724 3.544 -3.028 -13.336 -20.744
Social Capital - - - 86 84 83 81 81 81 80
Debts - - - 3.237 10.623 1.281 16.123 19.844 26.536 31.094
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 6.645 euro in 2024 which includes Inventories of 27 euro, Receivables of 4.082 euro and cash availability of 2.536 euro.
The company's Equity was valued at -20.744 euro, while total Liabilities amounted to 31.094 euro. Equity decreased by -7.483 euro, from -13.336 euro in 2023, to -20.744 in 2024.

Risk Reports Prices

Reviews - Invictus Pharmaceutical S.r.l.

Comments - Invictus Pharmaceutical S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.